Clinical Trial Update: A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response. [NA]

View source ↗

Summary

Completed clinical trial evaluating vitamin B prophylaxis to reduce paclitaxel-induced neuropathy and assessing gabapentin use in diabetic ovarian cancer patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Ovarian Cancer

Drugs mentioned

• Gabapentin (Gabapentin)
• PACLITAXEL (PACLITAXEL)
• Vitamin B complex (Vitamin B complex)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Peripheral Neuropathy, Chemotherapy-induced, Disease Management | NA | Status: COMPLETED